TY - JOUR AU - Zafiriou, S. AU - Stanners, S. R. AU - Saad, S. AU - Polhill, T. S. AU - Poronnik, P. AU - Pollock, C. A. PY - 2005 DA - 2005// TI - Pioglitazone inhibits cell growth and reduces matrix production in human kidney fibroblasts JO - J Am Soc Nephrol VL - 16 UR - https://doi.org/10.1681/ASN.2004040278 DO - 10.1681/ASN.2004040278 ID - Zafiriou2005 ER - TY - JOUR AU - Arkan, M. C. AU - Hevener, A. L. AU - Greten, F. R. AU - Maeda, S. AU - Li, Z. W. AU - Long, J. M. AU - Wynshaw-Boris, A. AU - Poli, G. AU - Olefsky, J. AU - Karin, M. PY - 2005 DA - 2005// TI - IKK-beta links inflammation to obesity-induced insulin resistance JO - Nat Med VL - 11 UR - https://doi.org/10.1038/nm1185 DO - 10.1038/nm1185 ID - Arkan2005 ER - TY - JOUR AU - Kovacs, P. AU - Stumvoll, M. PY - 2005 DA - 2005// TI - Fatty acids and insulin resistance in muscle and liver JO - Best Pract Res Clin Endocrinol Metab VL - 19 UR - https://doi.org/10.1016/j.beem.2005.07.003 DO - 10.1016/j.beem.2005.07.003 ID - Kovacs2005 ER - TY - JOUR AU - Dresner, A. AU - Laurent, D. AU - Marcucci, M. AU - Griffin, M. E. AU - Dufour, S. AU - Cline, G. W. AU - Slezak, L. A. AU - Andersen, D. K. AU - Hundal, R. S. AU - Rothman, D. L. PY - 1999 DA - 1999// TI - Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity JO - J Clin Invest VL - 103 UR - https://doi.org/10.1172/JCI5001 DO - 10.1172/JCI5001 ID - Dresner1999 ER - TY - JOUR AU - Ghazzi, M. N. AU - Perez, J. E. AU - Antonucci, T. K. AU - Driscoll, J. H. AU - Huang, S. M. AU - Faja, B. W. AU - Whitcomb, R. W. PY - 1997 DA - 1997// TI - Cardiac and glycemic benefits of troglitazone treatment in NIDDM. The Troglitazone Study Group JO - Diabetes VL - 46 UR - https://doi.org/10.2337/diab.46.3.433 DO - 10.2337/diab.46.3.433 ID - Ghazzi1997 ER - TY - JOUR AU - Bastarrachea, R. A. AU - Lopez-Alvarenga, J. C. AU - Bolado-Garcia, V. E. AU - Tellez-Mendoza, J. AU - Laviada-Molina, H. AU - Comuzzie, A. G. PY - 2007 DA - 2007// TI - Macrophages, inflammation, adipose tissue, obesity and insulin resistance JO - Gac Med Mex VL - 143 ID - Bastarrachea2007 ER - TY - JOUR AU - Yuan, M. AU - Konstantopoulos, N. AU - Lee, J. AU - Hansen, L. AU - Li, Z. W. AU - Karin, M. AU - Shoelson, S. E. PY - 2001 DA - 2001// TI - Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta JO - Science VL - 293 UR - https://doi.org/10.1126/science.1061620 DO - 10.1126/science.1061620 ID - Yuan2001 ER - TY - JOUR AU - Boden, G. AU - Laakso, M. PY - 2004 DA - 2004// TI - Lipids and glucose in type 2 diabetes: what is the cause and effect? JO - Diabetes Care VL - 27 UR - https://doi.org/10.2337/diacare.27.9.2253 DO - 10.2337/diacare.27.9.2253 ID - Boden2004 ER - TY - JOUR AU - DeFronzo, R. A. AU - Ferrannini, E. PY - 1991 DA - 1991// TI - Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease JO - Diabetes Care VL - 14 UR - https://doi.org/10.2337/diacare.14.3.173 DO - 10.2337/diacare.14.3.173 ID - DeFronzo1991 ER - TY - JOUR AU - Liu, Z. AU - Fu, C. AU - Wang, W. AU - Xu, B. PY - 2010 DA - 2010// TI - Prevalence of chronic complications of type 2 diabetes mellitus in outpatients - a cross-sectional hospital based survey in urban China JO - Health Qual Life Outcomes VL - 8 UR - https://doi.org/10.1186/1477-7525-8-62 DO - 10.1186/1477-7525-8-62 ID - Liu2010 ER - TY - JOUR AU - Bailey, C. J. AU - Day, C. PY - 2004 DA - 2004// TI - Avandamet: combined metformin-rosiglitazone treatment for insulin resistance in type 2 diabetes JO - Int J Clin Pract VL - 58 UR - https://doi.org/10.1111/j.1742-1241.2004.00318.x DO - 10.1111/j.1742-1241.2004.00318.x ID - Bailey2004 ER - TY - JOUR AU - Bakris, G. AU - Viberti, G. AU - Weston, W. M. AU - Heise, M. AU - Porter, L. E. AU - Freed, M. I. PY - 2003 DA - 2003// TI - Rosiglitazone reduces urinary albumin excretion in type II diabetes JO - J Hum Hypertens VL - 17 UR - https://doi.org/10.1038/sj.jhh.1001444 DO - 10.1038/sj.jhh.1001444 ID - Bakris2003 ER - TY - JOUR AU - Bell, D. S. PY - 2003 DA - 2003// TI - Beneficial effects resulting from thiazolidinediones for treatment of type 2 diabetes mellitus JO - Postgrad Med VL - Spec No ID - Bell2003 ER - TY - JOUR AU - DeFronzo, R. A. AU - Goodman, A. M. PY - 1995 DA - 1995// TI - Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group JO - N Engl J Med VL - 333 UR - https://doi.org/10.1056/NEJM199508313330902 DO - 10.1056/NEJM199508313330902 ID - DeFronzo1995 ER - TY - JOUR AU - Einhorn, D. AU - Rendell, M. AU - Rosenzweig, J. AU - Egan, J. W. AU - Mathisen, A. L. AU - Schneider, R. L. PY - 2000 DA - 2000// TI - Pioglitazone hydrochloride in combination with metformin in the treatment of type 2 diabetes mellitus: a randomized, placebo-controlled study. The Pioglitazone 027 Study Group JO - Clin Ther VL - 22 UR - https://doi.org/10.1016/S0149-2918(00)83039-8 DO - 10.1016/S0149-2918(00)83039-8 ID - Einhorn2000 ER - TY - JOUR AU - Maggs, D. G. AU - Buchanan, T. A. AU - Burant, C. F. AU - Cline, G. AU - Gumbiner, B. AU - Hsueh, W. A. AU - Inzucchi, S. AU - Kelley, D. AU - Nolan, J. AU - Olefsky, J. M. PY - 1998 DA - 1998// TI - Metabolic effects of troglitazone monotherapy in type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial JO - Ann Intern Med VL - 128 UR - https://doi.org/10.7326/0003-4819-128-3-199802010-00002 DO - 10.7326/0003-4819-128-3-199802010-00002 ID - Maggs1998 ER - TY - JOUR AU - Boyle, P. J. AU - King, A. B. AU - Olansky, L. AU - Marchetti, A. AU - Lau, H. AU - Magar, R. AU - Martin, J. PY - 2002 DA - 2002// TI - Effects of pioglitazone and rosiglitazone on blood lipid levels and glycemic control in patients with type 2 diabetes mellitus: a retrospective review of randomly selected medical records JO - Clin Ther VL - 24 UR - https://doi.org/10.1016/S0149-2918(02)85040-8 DO - 10.1016/S0149-2918(02)85040-8 ID - Boyle2002 ER - TY - JOUR AU - Fan, C. AU - Li, Q. AU - Zhang, Y. AU - Liu, X. AU - Luo, M. AU - Abbott, D. AU - Zhou, W. AU - Engelhardt, J. F. PY - 2004 DA - 2004// TI - IkappaBalpha and IkappaBbeta possess injury context-specific functions that uniquely influence hepatic NF-kappaB induction and inflammation JO - J Clin Invest VL - 113 UR - https://doi.org/10.1172/JCI17337 DO - 10.1172/JCI17337 ID - Fan2004 ER - TY - JOUR AU - Zhang, C. Y. AU - Parton, L. E. AU - Ye, C. P. AU - Krauss, S. AU - Shen, R. AU - Lin, C. T. AU - Porco, J. A. AU - Lowell, B. B. PY - 2006 DA - 2006// TI - Genipin inhibits UCP2-mediated proton leak and acutely reverses obesity- and high glucose-induced beta cell dysfunction in isolated pancreatic islets JO - Cell Metab VL - 3 UR - https://doi.org/10.1016/j.cmet.2006.04.010 DO - 10.1016/j.cmet.2006.04.010 ID - Zhang2006 ER - TY - JOUR AU - Sheng, L. AU - Qian, Z. AU - Zheng, S. AU - Xi, L. PY - 2006 DA - 2006// TI - Mechanism of hypolipidemic effect of crocin in rats: crocin inhibits pancreatic lipase JO - Eur J Pharmacol VL - 543 UR - https://doi.org/10.1016/j.ejphar.2006.05.038 DO - 10.1016/j.ejphar.2006.05.038 ID - Sheng2006 ER - TY - JOUR AU - Herder, C. AU - Schneitler, S. AU - Rathmann, W. AU - Haastert, B. AU - Schneitler, H. AU - Winkler, H. AU - Bredahl, R. AU - Hahnloser, E. AU - Martin, S. PY - 2007 DA - 2007// TI - Low-grade inflammation, obesity, and insulin resistance in adolescents JO - J Clin Endocrinol Metab VL - 92 UR - https://doi.org/10.1210/jc.2007-0955 DO - 10.1210/jc.2007-0955 ID - Herder2007 ER - TY - JOUR AU - Shulman, G. I. PY - 2000 DA - 2000// TI - Cellular mechanisms of insulin resistance JO - J Clin Invest VL - 106 UR - https://doi.org/10.1172/JCI10583 DO - 10.1172/JCI10583 ID - Shulman2000 ER - TY - JOUR AU - Hotamisligil, G. S. PY - 2006 DA - 2006// TI - Inflammation and metabolic disorders JO - Nature VL - 444 UR - https://doi.org/10.1038/nature05485 DO - 10.1038/nature05485 ID - Hotamisligil2006 ER - TY - JOUR AU - Del Prato, S. AU - Volpe, L. PY - 2004 DA - 2004// TI - Rosiglitazone plus metformin: combination therapy for Type 2 diabetes JO - Expert Opin Pharmacother VL - 5 UR - https://doi.org/10.1517/14656566.5.6.1411 DO - 10.1517/14656566.5.6.1411 ID - Del Prato2004 ER - TY - JOUR AU - Marcy, T. R. AU - Britton, M. L. AU - Blevins, S. M. PY - 2004 DA - 2004// TI - Second-generation thiazolidinediones and hepatotoxicity JO - Ann Pharmacother VL - 38 UR - https://doi.org/10.1345/aph.1E072 DO - 10.1345/aph.1E072 ID - Marcy2004 ER - TY - JOUR AU - Fukuen, S. AU - Iwaki, M. AU - Yasui, A. AU - Makishima, M. AU - Matsuda, M. AU - Shimomura, I. PY - 2005 DA - 2005// TI - Sulfonylurea agents exhibit peroxisome proliferator-activated receptor gamma agonistic activity JO - J Biol Chem VL - 280 UR - https://doi.org/10.1074/jbc.M412113200 DO - 10.1074/jbc.M412113200 ID - Fukuen2005 ER - TY - JOUR AU - Yue, T. L. PY - 2003 DA - 2003// TI - Cardioprotective effects of thiazolidinediones, peroxisome proliferator-activated receptor-gamma agonists JO - Drugs Today (Barc) VL - 39 UR - https://doi.org/10.1358/dot.2003.39.12.799413 DO - 10.1358/dot.2003.39.12.799413 ID - Yue2003 ER - TY - JOUR AU - Goldstein, B. J. AU - Cobitz, A. R. AU - Hand, L. M. AU - Chen, H. PY - 2003 DA - 2003// TI - Are the metabolic effects of rosiglitazone influenced by baseline glycaemic control? JO - Curr Med Res Opin VL - 19 UR - https://doi.org/10.1185/030079903125001695 DO - 10.1185/030079903125001695 ID - Goldstein2003 ER - TY - JOUR AU - Kermani, A. AU - Garg, A. PY - 2003 DA - 2003// TI - Thiazolidinedione-associated congestive heart failure and pulmonary edema JO - Mayo Clin Proc VL - 78 UR - https://doi.org/10.4065/78.9.1088 DO - 10.4065/78.9.1088 ID - Kermani2003 ER - TY - JOUR AU - Lin, E. H. AU - Katon, W. AU - Von Korff, M. AU - Rutter, C. AU - Simon, G. E. AU - Oliver, M. AU - Ciechanowski, P. AU - Ludman, E. J. AU - Bush, T. AU - Young, B. PY - 2004 DA - 2004// TI - Relationship of depression and diabetes self-care, medication adherence, and preventive care JO - Diabetes Care VL - 27 UR - https://doi.org/10.2337/diacare.27.9.2154 DO - 10.2337/diacare.27.9.2154 ID - Lin2004 ER - TY - JOUR AU - Knowler, W. C. AU - Barrett-Connor, E. AU - Fowler, S. E. AU - Hamman, R. F. AU - Lachin, J. M. AU - Walker, E. A. AU - Nathan, D. M. PY - 2002 DA - 2002// TI - Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin JO - N Engl J Med VL - 346 UR - https://doi.org/10.1056/NEJMoa012512 DO - 10.1056/NEJMoa012512 ID - Knowler2002 ER - TY - JOUR AU - Scheen, A. J. PY - 2004 DA - 2004// TI - Combined thiazolidinedione-insulin therapy: should we be concerned about safety? JO - Drug Saf VL - 27 UR - https://doi.org/10.2165/00002018-200427120-00002 DO - 10.2165/00002018-200427120-00002 ID - Scheen2004 ER - TY - JOUR AU - Zhou, J. AU - Huang, K. PY - 2009 DA - 2009// TI - Peroxynitrite mediates muscle insulin resistance in mice via nitration of IRbeta/IRS-1 and Akt JO - Toxicol Appl Pharmacol VL - 241 UR - https://doi.org/10.1016/j.taap.2009.08.005 DO - 10.1016/j.taap.2009.08.005 ID - Zhou2009 ER - TY - JOUR AU - Elias, J. M. AU - Gown, A. M. AU - Nakamura, R. M. AU - Wilbur, D. C. AU - Herman, G. E. AU - Jaffe, E. S. AU - Battifora, H. AU - Brigati, D. J. PY - 1989 DA - 1989// TI - Quality control in immunohistochemistry. Report of a workshop sponsored by the Biological Stain Commission JO - Am J Clin Pathol VL - 92 UR - https://doi.org/10.1093/ajcp/92.6.836 DO - 10.1093/ajcp/92.6.836 ID - Elias1989 ER - TY - JOUR AU - Xu, Y. P. AU - Liang, L. AU - Wang, X. M. PY - 2011 DA - 2011// TI - The levels of Pdx1/insulin, Cacna1c and Cacna1d, and beta-cell mass in a rat model of intrauterine undernutrition JO - J Matern Fetal Neonatal Med VL - 24 UR - https://doi.org/10.3109/14767058.2010.497571 DO - 10.3109/14767058.2010.497571 ID - Xu2011 ER - TY - JOUR AU - Salgado, A. L. AU - Carvalho, L. AU - Oliveira, A. C. AU - Santos, V. N. AU - Vieira, J. G. AU - Parise, E. R. PY - 2010 DA - 2010// TI - Insulin resistance index (HOMA-IR) in the differentiation of patients with non-alcoholic fatty liver disease and healthy individuals JO - Arq Gastroenterol VL - 47 UR - https://doi.org/10.1590/S0004-28032010000200009 DO - 10.1590/S0004-28032010000200009 ID - Salgado2010 ER - TY - JOUR AU - Retnakaran, R. PY - 2010 DA - 2010// TI - The insulin secretion-sensitivity index-2 (ISSI-2) and the measurement of beta-cell function in women with gestational diabetes JO - Endocr J VL - 57 UR - https://doi.org/10.1507/endocrj.K10E-279 DO - 10.1507/endocrj.K10E-279 ID - Retnakaran2010 ER - TY - JOUR AU - Ranta, F. AU - Avram, D. AU - Berchtold, S. AU - Dufer, M. AU - Drews, G. AU - Lang, F. AU - Ullrich, S. PY - 2006 DA - 2006// TI - Dexamethasone induces cell death in insulin-secreting cells, an effect reversed by exendin-4 JO - Diabetes VL - 55 UR - https://doi.org/10.2337/db05-1220 DO - 10.2337/db05-1220 ID - Ranta2006 ER - TY - JOUR AU - Ohneda, M. AU - Johnson, J. H. AU - Inman, L. R. AU - Unger, R. H. PY - 1993 DA - 1993// TI - GLUT-2 function in glucose-unresponsive beta cells of dexamethasone-induced diabetes in rats JO - J Clin Invest VL - 92 UR - https://doi.org/10.1172/JCI116788 DO - 10.1172/JCI116788 ID - Ohneda1993 ER - TY - JOUR AU - Gremlich, S. AU - Roduit, R. AU - Thorens, B. PY - 1997 DA - 1997// TI - Dexamethasone induces posttranslational degradation of GLUT2 and inhibition of insulin secretion in isolated pancreatic beta cells. Comparison with the effects of fatty acids JO - J Biol Chem VL - 272 UR - https://doi.org/10.1074/jbc.272.6.3216 DO - 10.1074/jbc.272.6.3216 ID - Gremlich1997 ER - TY - JOUR AU - Philippe, J. AU - Giordano, E. AU - Gjinovci, A. AU - Meda, P. PY - 1992 DA - 1992// TI - Cyclic adenosine monophosphate prevents the glucocorticoid-mediated inhibition of insulin gene expression in rodent islet cells JO - J Clin Invest VL - 90 UR - https://doi.org/10.1172/JCI116108 DO - 10.1172/JCI116108 ID - Philippe1992 ER - TY - JOUR AU - Ullrich, S. AU - Berchtold, S. AU - Ranta, F. AU - Seebohm, G. AU - Henke, G. AU - Lupescu, A. AU - Mack, A. F. AU - Chao, C. M. AU - Su, J. AU - Nitschke, R. PY - 2005 DA - 2005// TI - Serum- and glucocorticoid-inducible kinase 1 (SGK1) mediates glucocorticoid-induced inhibition of insulin secretion JO - Diabetes VL - 54 UR - https://doi.org/10.2337/diabetes.54.4.1090 DO - 10.2337/diabetes.54.4.1090 ID - Ullrich2005 ER - TY - JOUR AU - Kruszynska, Y. T. AU - Mukherjee, R. AU - Jow, L. AU - Dana, S. AU - Paterniti, J. R. AU - Olefsky, J. M. PY - 1998 DA - 1998// TI - Skeletal muscle peroxisome proliferator- activated receptor-gamma expression in obesity and non- insulin-dependent diabetes mellitus JO - J Clin Invest VL - 101 UR - https://doi.org/10.1172/JCI1076 DO - 10.1172/JCI1076 ID - Kruszynska1998 ER - TY - JOUR AU - Antuna-Puente, B. AU - Feve, B. AU - Fellahi, S. AU - Bastard, J. P. PY - 2007 DA - 2007// TI - Obesity, inflammation and insulin resistance: which role for adipokines JO - Therapie VL - 62 UR - https://doi.org/10.2515/therapie:2007055 DO - 10.2515/therapie:2007055 ID - Antuna-Puente2007 ER - TY - JOUR AU - Takashima, T. AU - Fujiwara, Y. AU - Higuchi, K. AU - Arakawa, T. AU - Yano, Y. AU - Hasuma, T. AU - Otani, S. PY - 2001 DA - 2001// TI - PPAR-gamma ligands inhibit growth of human esophageal adenocarcinoma cells through induction of apoptosis, cell cycle arrest and reduction of ornithine decarboxylase activity JO - Int J Oncol VL - 19 ID - Takashima2001 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6882/14/30/prepub UR - http://www.biomedcentral.com/1472-6882/14/30/prepub ID - ref46 ER -